Showing results (191-200 of 520) with videos related to

Sort By:
Pageof 52
Hypertension (Dallas, Tex. : 1979)|February 26, 2019
Productivity Burden of Hypertension in AustraliaThomas R Hird, Ella Zomer, Alice J Owen, et al.
The Knee|March 27, 2012
The association between radiographic severity and pre-operative function in patients undergoing primary knee replacement for osteoarthritisMichelle M Dowsey, Paul Dieppe, Stefan Lohmander, et al.
Cardiovascular Therapeutics|September 3, 2011
Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian CohortZanfina Ademi, Danny Liew, Bruce Hollingsworth, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 26, 2010
Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registryZanfina Ademi, Danny Liew, Bruce Hollingsworth, et al.
Heart (British Cardiac Society)|July 27, 2013
Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based studyAnthony S Gunnell, Kristjana Einarsdóttir, Frank Sanfilippo, et al.
Pharmacoeconomics|August 25, 2022
Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian RandomisationZanfina Ademi, Jedidiah I Morton, Danny Liew, et al.
Plos One|April 13, 2018
Cost of gastroenteritis in Australia: A healthcare perspectiveS Fiona Barker, Ella Zomer, Joanne O'Toole, et al.
BMJ Open|December 18, 2019
Economic evaluation of clinical quality registries: a systematic reviewPeter Lee, Ken Chin, Danny Liew, et al.
Leukemia Research|January 22, 2022
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare systemCatriona Parker, Darshini Ayton, Ella Zomer, et al.
Current Problems in Cardiology|April 23, 2022
A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes MellitusDina Abushanab, Daoud Al-Badriyeh, Clara Marquina, et al.
Pageof 52